We invest in Smart Data & Digital Health (focusing on the oncology and infectious disease applications)
By Smart Data we mean companies that leverage medical data and AI to have an impact on either the patient journey or the development of pharmaceutical products. We are interested for example in real world data, patient recruitment and adherence.
By Digital Health we mean tools and technologies that add medical value to patient care, such as digital patient monitoring, digital therapeutics, or clinical decision support systems. Consumer products and wellness are outside of our investment focus.
Late pilot or early commercial
Series A and B
Our typical initial investment
$3M - 5M
Our recent investments
A DTx platform in oncology creating patient engagement and leading positive health outcomes